# Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

> **NCT06218433** · NA · RECRUITING · sponsor: **Tampere University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Urothelial Carcinoma
- Lynch Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** Urothelial cancer screening using urine tumor DNA test
- **DIAGNOSTIC_TEST:** Urothelial cancer screening using urine cytology (comparator)

## Key facts

- **NCT ID:** NCT06218433
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-10
- **Primary completion:** 2026-12-30
- **Final completion:** 2034-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06218433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06218433, "Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06218433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*